Literature DB >> 10197141

The effect of cetirizine on symptoms and signs of nasal polyposis.

R Haye1, J P Aanesen, B Burtin, F Donnelly, C Duby.   

Abstract

Forty-five patients with residual or recurrent nasal polyposis after ethmoidectomy were treated with either cetirizine at twice the daily recommended (20 mg) dose or placebo for three months. The number and size of polyps remained unchanged during the study period. Cetirizine was found to reduce nasal sneezing and rhinorrhoea effectively. The drug also had a beneficial effect on nasal obstruction in the latter part of the study. The side effects of 20 mg (double the recommended daily adult dose) of cetirizine were few and comparable to placebo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10197141     DOI: 10.1017/s0022215100142422

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  9 in total

Review 1.  Role of medical therapy in the management of nasal polyps.

Authors:  Isam Alobid; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

Review 2.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Pharmacological management of nasal polyposis.

Authors:  Claus Bachert; Jean-Baptiste Watelet; Philippe Gevaert; Paul Van Cauwenberge
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Treatment of congestion in upper respiratory diseases.

Authors:  Eli O Meltzer; Fernan Caballero; Leonard M Fromer; John H Krouse; Glenis Scadding
Journal:  Int J Gen Med       Date:  2010-04-08

Review 5.  Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis.

Authors:  M Boyd Gillespie; J David Osguthorpe
Journal:  Curr Allergy Asthma Rep       Date:  2004-11       Impact factor: 4.919

Review 6.  Actual concepts in rhinosinusitis: a review of clinical presentations, inflammatory pathways, cytokine profiles, remodeling, and management.

Authors:  Philippe Eloy; Anne Lise Poirrier; Clotilde De Dorlodot; Thibaut Van Zele; Jean Baptiste Watelet; Bernard Bertrand
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806

7.  Chronic rhinosinusitis and emerging treatment options.

Authors:  Patorn Piromchai; Pornthep Kasemsiri; Supawan Laohasiriwong; Sanguansak Thanaviratananich
Journal:  Int J Gen Med       Date:  2013-06-07

8.  A review of nasal polyposis.

Authors:  Jonathan Ray Newton; Kim Wong Ah-See
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

9.  Smell Decline as a good Predictor of Sinonasal Polyposis Recurrence after Endoscopic Surgery.

Authors:  Mahdi Bakhshaee; Mohammad Reza Sharifian; Amir Hossain Ghazizadeh; Kianoosh Nahid; Karim Jalaeian Samani
Journal:  Iran J Otorhinolaryngol       Date:  2016-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.